Industry Standing Group

The European Medicine Agency (EMA) has an Industry Standing Group (ISG) to enable regular dialogue with industry stakeholders on issues relating to human medicines and medical devices. This group also facilitates the implementation of new legislation in the European Union (EU). 

EMA established the group in 2022 to help implement EMA's extended mandate in addressing public health emergencies, in line with Regulation (EU) 2022/123.

This enabled EMA to engage with representatives of the medical device industry, notified bodies and the pharmaceutical industry in order to implement the Regulation. 

The group complements other forums for EMA dialogue with industry, such as EMA's industry stakeholder meetings and bilateral meetings with industry associations representing specific sectors.

Also on this topic

• Industry Standing Group meetings

Members and mandate

EMA will provide information on the group's mandate and member associations as soon as available.

Meetings

The group meets four times per year. For more information, see the dedicated meeting page: 

• Industry Standing Group meetings

EMA also hosts industry stakeholder meetings where members discuss operational aspects linked to medicine development, the centralised procedure and pharmacovigilance:

• Industry stakeholder meetings

In addition, EMA organises bilateral meetings with industry associations:

• Industry annual bilateral meetings

EMA working parties also discuss related issues:

• Working parties and other groups

Mandate, objectives and composition of Industry Standing Group (ISG)

Reference Number: EMA/52789/2022